Glucagon-like peptide receptor agonists (GLP-1RAs) as cardiovascular risk modifiers in obstructive sleep apnea and obesity: a real-world study.

J Clin Sleep Med · 2026 · PMC13323676 · PMID 42387223

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Prior randomized trials, such as SUSTAIN-6 [ 2 ], demonstrated a nonsignificant trend toward reduced nonfatal myocardial infarction with semaglutide.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.